ライフサイエンスコーパス: ischemic time

1 ion of some of these lncRNAs correlates with ischemic time.

2 nd these factors were related to duration of ischemic time.

3 portal venous lactate concentration and cold ischemic time.

4 titis C virus + serology, donor age and cold ischemic time.

5 en eligible for organ donation based on warm ischemic time.

6 ransplantation and cases with prolonged cold ischemic time.

7 der cardiopulmonary resuscitation, and total ischemic time.

8 hour without ventilation, defining the warm ischemic time.

9 ed leading to a potential reduction in total ischemic time.

10 uch arguments and find ways to shorten total ischemic time.

11 t of retrieval, and so does not include cold ischemic time.

12 inal donors or organs experiencing prolonged ischemic times.

13 ic transplants and cases with prolonged cold ischemic times.

14 to abrogate IRI when subjected to increasing ischemic times.

15 ive field in order to prevent prolonged warm ischemic times.

16 ar efficacy in kidney preservation at longer ischemic times.

17 splants (1.556, P<0.01), with prolonged cold ischemic time (1.097, P=0.03), for black recipients (1.2

18 .44 vs. 3.12+/-0.36 hr, P<0.05) and the warm ischemic time (1.23+/-0.54 vs. 3.91+/-0.53 min, P<0.05).

19 ibrillation (81% vs 46%; p < 0.001), shorter ischemic time (18.9 vs 26.4 min; p = 0.003), more witnes

20 er liter; P<0.0001) despite having identical ischemic times (185+/-8 minutes versus 181+/-5 minutes;

21 ate (182.88 +/- 69.80 vs. 221.31 +/- 56.91), ischemic time (187.4 +/- 63.1 vs. 215.5 +/- 68.1), and d

22 tation (8.6 vs 7.0 min; p < 0.001) and total ischemic time (25.6 vs 22.3 min; p < 0.001) and less oft

23 vs. 47 years), donor age (29 vs. 28 years), ischemic time (3.0 vs. 2.9 hr), and pretransplant medica

24 of graft loss per hour increase in the total ischemic time (adjusted hazard ratio, 1.09; 95% confiden

25 chemia time greater than 30 minutes and cold ischemic time also occurred over the same period.

26 , anastomotic time (P=0.0012), combined cold ischemic time and anastomotic time (P=0.00018), and body

27 analyses accounting for the effects of cold ischemic time and donor age, Treg suppressive function d

28 tors were LTx from a female donor, prolonged ischemic time and number of perioperative red blood cell

29 ociated with first transplants, shorter cold ischemic time and operative time, and less intraoperativ

30 Prolonged cold ischemic time and recipient life support were predictors

31 is associated with substantial reductions in ischemic time and treatment delays.

32 rgery, and concerns continue about prolonged ischemic times and risk of bleeding in various MIS setti

33 nd severity of injury, vascular examination, ischemic times) and operative (methods of arterial repai

34 r pulmonary vascular resistance index, graft ischemic time, and cardiopulmonary bypass time, donor lo

35 ty, increased cardiopulmonary bypass time or ischemic time, and circulatory arrest; and postoperative

36 edema, donor/recipient HLA-DR mismatch, cold ischemic time, and donor age were independently associat

37 nces in the first warm ischemic period, cold ischemic time, and donor age.

38 ioplegia volume per anastomosis or minute of ischemic time, and less hot-shot use.

39 cluded older age at transplant, shorter cold ischemic time, and single strictures.

40 , blood product use, primary diagnosis, cold ischemic time, and surgeon were similar between the grou

41 ease, diabetes status, body mass index, cold ischemic time, and UNOS status.

42 are very promising, demonstrating short warm ischemic times, and a low rate of complication and recur

43 s, primary diagnosis, surgeon, warm and cold ischemic times, and blood product use were recorded.

44 lder recipient age, older donors with longer ischemic times, and pre-HT Fontan operations.

45 y of poor ex vivo perfusion, had longer cold ischemic times, and were transplanted into older recipie

46 Pre-transplant VAD and prolonged ischemic times are more important determinants of PGD.

47 identified younger age and longer donor warm ischemic time as risk factors for homograft failure and

48 dema after lung transplantation, with longer ischemic times associated with greater permeability to p

49 Mean warm ischemic time at recovery in the DCD group was 17.8 +/-

50 e effect of long (n = 16) and short (n = 12) ischemic times (average of 6 h and of 73 min, respective

51 Due to unavoidable prolonged ischemic time before procurement in donation after cardi

52 relevant endpoints across a spectrum of warm ischemic times, before and during ex vivo heart perfusio

53 These differences occurred despite total ischemic time being significantly longer in the long-int

54 The finding of similar fractions of ischemic time between awake and sedated states persisted

55 ercutaneous coronary intervention with known ischemic times between 1 and 6 hours identified 165 pati

56 irst ST-elevation myocardial infarction with ischemic times between 1 and 6 hours who received primar

57 etransplantation), bypass times, and cardiac ischemic times between the two groups.

58 Increased cold ischemic time but neither donor age nor intensity of ino

59 ntigen mismatches (chi-square 3.06) and cold ischemic time (chi-square 3.23).

60 9 renal transplants were performed with cold ischemic times (CI) greater than 16 hr (UW 87, HTK 62) a

61 also examined the relationship between cold ischemic time (CIT) and likelihood of surgical complicat

62 Total cold ischemic time (CIT) consisted of the time from retrieval

63 Multivariate analysis revealed that cold ischemic time (CIT) greater than 8 hours (HR: 2.46; P =

64 We stratified on basis of cold ischemic time (CIT) to determine the interaction of pres

65 Mean cold ischemic time (CIT) was 5.4 hours in O and 7.3 hours in

66 The degree of HLA matching, the cold ischemic time (CIT), the balance of exchange, and graft

67 Long cold ischemic time (CIT), with or without delayed graft funct

68 lsatile perfusion (PP) across different cold ischemic times (CIT) within different donor groups is un

69 ients in the SAC group had longer myocardial ischemic time compared with those in the PAC group (mean

70 erved in the Celsior group despite prolonged ischemic times compared with LPD.

71 opsies collected at the beginning and end of ischemic time (cross-clamp time).

72 iabetes, body mass index, waiting time, cold ischemic time, delayed graft function, and coronary risk

73 erences as dramatic as those associated with ischemic times, despite uniform protein expression profi

74 ls during sedative interruption, fraction of ischemic time did not differ between the time awake vs.

75 not long-term, graft survival, whereas cold ischemic time did not have statistically significant ass

76 avenous glycoprotein IIb/IIIa inhibitors and ischemic time did not seem to influence any potential be

77 regards to recipient age, recipient gender, ischemic time, donor age, and donor gender.

78 was a significant interaction between total ischemic time, donor age, and graft loss (P value for in

79 iate logistic regression accounting for cold ischemic time, donor age, previous transplant, and pretr

80 lant variables associated with PGF included: ischemic time, donor gender, donor age, multiorgan donat

81 As warm ischemic time exposure increased in DCD groups, fewer he

82 dualized score procedure was used to correct ischemic time for each patient's simultaneously measured

83 e between the two groups with regard to cold ischemic time for organ storage, donor age, recipient ag

84 The allograft warm ischemic time for the laparoscopic cases was 4.2+/-1.3 m

85 The mean cold ischemic times for the kidney and the pancreas were 15+/

86 ally and shared nationally, livers with cold ischemic time >12 hours, livers from hepatitis C virus p

87 raction, shock at the time of admission, and ischemic time >25 minutes) of 0 to 5 was: 7.1% versus 10

88 Pre-transplant VAD and prolonged total ischemic times (> or = 4.5 hours) were independent predi

89 antibodies (PRAs) (>20%), and prolonged cold ischemic times (>24 hours) in each group.

90 teen children received organs with prolonged ischemic times (>8 hours)(PIT) compared with 14 with sho

91 Prolonged donor warm ischemic time has been identified as the key factor resp

92 on graft outcomes, such that the duration of ischemic time has the greatest impact on graft survival

93 dependence on marginal grafts with prolonged ischemic times have meant that new methods are needed to

94 were MVO (hazard ratio, 3.418; P=0.046) and ischemic time (hazard ratio, 1.016; P<0.001).

95 ive blood loss, surgical reexploration, long ischemic times, immediate postoperative cardiovascular d

96 Expression levels of IL-8 correlate with the ischemic time imposed on the renal graft.

97 The cold and warm ischemic times improved significantly during the second

98 Concern exists that donor warm ischemic time in addition to subsequent cold ischemia-re

99 nd graft loss, cause of graft loss, and cold ischemic time in the geriatric population.

100 Total ischemic time (in hours) was defined as the time of the

101 Donor ischemic time increased from 150 to 166 minutes (P < .00

102 to examine whether older donor age and cold ischemic time interact to produce inferior allograft sur

103 ed odd of DGF compared with those with total ischemic time less than 14 hours.

104 Long ischemic times (LIT) led to significantly (p < 0.05) gre

105 n two episodes of acute rejection, and organ ischemic time longer than 180 minutes.

106 gh lactate levels are associated with longer ischemic times, longer duration of inotrope, and corresp

107 isolations (donor age 41-59, BMI 26-38, cold ischemic time < 10 h).

108 nfarction study that enrolled 1099 patients (ischemic time <6 hours) in Italy, Scotland, and China.

109 s index <35, non-status 1 registration, cold ischemic time <8 hours, and either hepatocellular carcin

110 (>8 hours)(PIT) compared with 14 with short ischemic times (< or =90 minutes)(SIT).

111 survival: donor and recipient demographics, ischemic time, LVAD, retransplantation, pretransplant pu

112 Donor warm ischemic time may predispose hepatic allografts to an in

113 ere less than 2 minutes, because longer warm ischemic times may make the use of heparin a more import

114 they are typically young and have short cold ischemic times, may be advantageous for HCV-infected pat

115 low esophageal temperature but not cerebral ischemic time (mean 32 minutes).

116 ting, waiting time (mean, 1.3 months), graft ischemic time (mean, 228 minutes; range, 68 to 479 minut

117 %, P < .001), despite a slightly longer cold ischemic time (median: 14.8 vs 14.1 hours, P < .001).

118 ravenous glycoprotein IIb/IIIa inhibitors or ischemic time might modify any clinical benefits observe

119 rtery injury include blunt trauma, prolonged ischemic times, musculoskeletal injuries, and venous dis

120 pulmonary vascular resistance index), donor ischemic time, occurrence of postoperative infections, e

121 Recipients with total ischemic time of 14 hours or longer experienced an incre

122 situ cardioplegic arrest was followed by an ischemic time of 3 or 6 hr, transplantation, and blood r

123 d criteria deceased donor kidneys with total ischemic time of less than 12 hours (SCD, <12), SCD of 1

124 ia/reperfusion injury by prolonging the cold ischemic time of the allograft did not affect the severi

125 achieved, age and gender of the donor, cold ischemic time of the graft, and matching of CMV serologi

126 l's solution was associated with longer cold ischemic time, older donors, kidney-only donors, donors

127 r age, the pathway of donor death, and total ischemic time on graft outcomes, such that the duration

128 ath and rejected due to prolonged donor warm ischemic times; one liver from a brain-death donor was d

129 AD, immunosuppression, sex, donor age, donor ischemic time, or cytomegalovirus between the two groups

130 megalovirus (CMV) status or blood type, cold ischemic times, or the incidence of outflow obstruction.

131 owed little development of OB, regardless of ischemic time (p < 0.05).

132 infection (4.9%, P = 0.001) and longer cold ischemic time (P = 0.001).

133 tion (p =.029) and inversely with graft cold ischemic time (p =.007).

134 ve transfusion requirements (P=0.0001), cold ischemic time (P<0.0001), use of roux-en-Y biliary anast

135 death (P=0.0053), donor age (P=0.0017), cold ischemic time (P=0.0009), anastomotic time (P=0.0012), c

136 ery thrombosis (P=0.0018) and prolonged cold ischemic time (P=0.034), were independent risk factors a

137 =0.17, 0.70, and 0.50, respectively) or with ischemic time (P=0.29, 0.66, and 0.58, respectively).

138 sed 2/2 PAI-1 genotyped allograft had longer ischemic times (P=0.02) than those recipients with a Tx

139 ype (DCD vs DBD), donor age, steatosis, cold ischemic time, peak aspartate transaminase, day 5 biliru

140 However, total ischemic time per 24 hours (15.0 +/- 21.4 versus 23.6 +/

141 21.4 versus 23.6 +/- 31.1 minutes, P = .02), ischemic time per episode (6.3 +/- 4.6 versus 9.0 +/- 8.

142 del adjusting for HCV-Donor Risk Index, warm ischemic time, pretransplant Model for Endstage Liver Di

143 , mean +/- standard error) compared to short ischemic times (ratio = 0.19 +/- 0.05).

144 s independently associated with PGD included ischemic time, recipient African American race, and reci

145 ents myocardial functional recovery after an ischemic time relevant to clinical cardiac transplantati

146 is report, we show that a modest increase in ischemic time results in conversion from a CD18-dependen

147 evity include younger age, longer donor warm ischemic time, smaller homograft size, use of aortic hom

148 acy of myocardial reperfusion, including the ischemic time, ST-segment elevation, angiographic blush

149 The MA group had longer operative and ischemic times than SA group.

150 The mean ischemic time to 50% myoglobin desaturation was, on aver

151 dding the donor-related variables of age and ischemic time to the model improved its performance in b

152 The total ischemic time to the organ was 50 minutes.

153 However, the contribution of ischemic time to this process remains unknown.

154 gender, type of LT, indication for LT, graft ischemic time, use of cardiopulmonary bypass, cytomegalo

155 is identified younger age, longer donor warm ischemic time, valve Z: value <2, and previous procedure

156 If cold ischemic time was > or =24 hr, there was a 2.19-fold inc

157 Mean cardiac ischemic time was 140 +/- 45 minutes.

158 The mean cold ischemic time was 16.5 hr in the two-layer group versus

159 Average donor ischemic time was 217 min.

160 Total ischemic time was 7.9 hr for both groups.

161 Mean warm ischemic time was limited at 238 +/- 112 seconds.

162 Mean cold ischemic time was longer in DKT (22.2+/-9.7 hr), but rat

163 Warm ischemic time was longer in the HA group (mean [SD] HA 5

164 and abdominal wall transplantation where the ischemic time was minimized by remotely revascularizing

165 Graft ischemic time was positively correlated with the degree

166 The total ischemic time was significantly longer for ECMO-rescued

167 Cold ischemic time was significantly longer in patients who r

168 The cumulative ischemic time was similar for the two groups ([mean +/-

169 Mean ischemic time was slightly but not significantly higher

170 estive heart failure, donor age and sex, and ischemic time were recorded.

171 It is important to note that our warm ischemic times were less than 2 minutes, because longer

172 Mean bypass and ischemic times were significantly longer in patients wit

173 Cold ischemic times were similar between groups, but more ECD

174 Warm and cold ischemic times were typically <45 min and <90 min, respe

175 16 to 1.34) in kidneys with total donor warm ischemic time (WIT) of 10-26 minutes to 2.67 (95% CI, 2.

176 (n=5) underwent left nephrectomy after warm ischemic times (WIT) of 0 or 30 min.

177 , we examined the relationship between total ischemic time with graft outcomes among recipients who r

178 eritransplant conditions, such as shortening ischemic times with the use of thrombolytic donor flush,

179 ars included increasing donor age, prolonged ischemic time, worsening recipient creatinine, recipient